UBS O'Connor »

Corbus Pharmaceuticals Hldgs shares owned by UBS O'Connor

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-03-31 $294k 7.5k 39.24

More positions owned by UBS O'Connor

Spirit Air Note1 (Principal)
Peloton In Note2 (Principal)
Ryanair Ho Spons (RYAAY)
Revance Th Note1 (Principal)
Occidental Petroleum Corporation (OXY)
Okta Cla (OKTA)
NVIDIA Corporation (NVDA)
New Provid Class (NPAB)
Acorda The Note6 (Principal)
Bandwidth Note0 (Principal)
Screaming Class
Norfolk Southern (NSC)
Pentair Pl SHS (PNR)
Broadcom (AVGO)
Autoliv (ALV)

View all positions for UBS O'Connor

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
BlackRock
Vanguard Group
Octagon Capital Advisors
State Street Corporation
Adage Capital Partners GP
Citadel Advisors
Darwin Global Management
Ikarian Capital
T. Rowe Price Associates
Morgan Stanley
Woodline Partners
Millennium Management
Assenagon Asset Management
Geode Capital Management

View all funds holding Corbus Pharmaceuticals Hldgs